Global HER2 Antibodies Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 97

Report ID: 19614

The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.

In 2018, the global HER2 Antibodies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global HER2 Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HER2 Antibodies development in United States, Europe and China.

The key players covered in this study
Novartis
Pfizer
Roche
Abnova
InvivoGen
Celltrion
Biocon
Novus Biologicals

Market segment by Type, the product can be split into
Trastuzumab
Lapatinib
Ado-trastuzumab emtansine
Pertuzumab
Everolimus

Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
E-commerce

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global HER2 Antibodies status, future forecast, growth opportunity, key market and key players.
To present the HER2 Antibodies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of HER2 Antibodies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global HER2 Antibodies Market Size Growth Rate by Type (2014-2025)
1.4.2 Trastuzumab
1.4.3 Lapatinib
1.4.4 Ado-trastuzumab emtansine
1.4.5 Pertuzumab
1.4.6 Everolimus
1.5 Market by Application
1.5.1 Global HER2 Antibodies Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 E-commerce
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 HER2 Antibodies Market Size
2.2 HER2 Antibodies Growth Trends by Regions
2.2.1 HER2 Antibodies Market Size by Regions (2014-2025)
2.2.2 HER2 Antibodies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 HER2 Antibodies Market Size by Manufacturers
3.1.1 Global HER2 Antibodies Revenue by Manufacturers (2014-2019)
3.1.2 Global HER2 Antibodies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global HER2 Antibodies Market Concentration Ratio (CR5 and HHI)
3.2 HER2 Antibodies Key Players Head office and Area Served
3.3 Key Players HER2 Antibodies Product/Solution/Service
3.4 Date of Enter into HER2 Antibodies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global HER2 Antibodies Market Size by Type (2014-2019)
4.2 Global HER2 Antibodies Market Size by Application (2014-2019)

5 United States
5.1 United States HER2 Antibodies Market Size (2014-2019)
5.2 HER2 Antibodies Key Players in United States
5.3 United States HER2 Antibodies Market Size by Type
5.4 United States HER2 Antibodies Market Size by Application

6 Europe
6.1 Europe HER2 Antibodies Market Size (2014-2019)
6.2 HER2 Antibodies Key Players in Europe
6.3 Europe HER2 Antibodies Market Size by Type
6.4 Europe HER2 Antibodies Market Size by Application

7 China
7.1 China HER2 Antibodies Market Size (2014-2019)
7.2 HER2 Antibodies Key Players in China
7.3 China HER2 Antibodies Market Size by Type
7.4 China HER2 Antibodies Market Size by Application

8 Japan
8.1 Japan HER2 Antibodies Market Size (2014-2019)
8.2 HER2 Antibodies Key Players in Japan
8.3 Japan HER2 Antibodies Market Size by Type
8.4 Japan HER2 Antibodies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia HER2 Antibodies Market Size (2014-2019)
9.2 HER2 Antibodies Key Players in Southeast Asia
9.3 Southeast Asia HER2 Antibodies Market Size by Type
9.4 Southeast Asia HER2 Antibodies Market Size by Application

10 India
10.1 India HER2 Antibodies Market Size (2014-2019)
10.2 HER2 Antibodies Key Players in India
10.3 India HER2 Antibodies Market Size by Type
10.4 India HER2 Antibodies Market Size by Application

11 Central & South America
11.1 Central & South America HER2 Antibodies Market Size (2014-2019)
11.2 HER2 Antibodies Key Players in Central & South America
11.3 Central & South America HER2 Antibodies Market Size by Type
11.4 Central & South America HER2 Antibodies Market Size by Application

12 International Players Profiles
12.1 Novartis
12.1.1 Novartis Company Details
12.1.2 Company Description and Business Overview
12.1.3 HER2 Antibodies Introduction
12.1.4 Novartis Revenue in HER2 Antibodies Business (2014-2019)
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Company Details
12.2.2 Company Description and Business Overview
12.2.3 HER2 Antibodies Introduction
12.2.4 Pfizer Revenue in HER2 Antibodies Business (2014-2019)
12.2.5 Pfizer Recent Development
12.3 Roche
12.3.1 Roche Company Details
12.3.2 Company Description and Business Overview
12.3.3 HER2 Antibodies Introduction
12.3.4 Roche Revenue in HER2 Antibodies Business (2014-2019)
12.3.5 Roche Recent Development
12.4 Abnova
12.4.1 Abnova Company Details
12.4.2 Company Description and Business Overview
12.4.3 HER2 Antibodies Introduction
12.4.4 Abnova Revenue in HER2 Antibodies Business (2014-2019)
12.4.5 Abnova Recent Development
12.5 InvivoGen
12.5.1 InvivoGen Company Details
12.5.2 Company Description and Business Overview
12.5.3 HER2 Antibodies Introduction
12.5.4 InvivoGen Revenue in HER2 Antibodies Business (2014-2019)
12.5.5 InvivoGen Recent Development
12.6 Celltrion
12.6.1 Celltrion Company Details
12.6.2 Company Description and Business Overview
12.6.3 HER2 Antibodies Introduction
12.6.4 Celltrion Revenue in HER2 Antibodies Business (2014-2019)
12.6.5 Celltrion Recent Development
12.7 Biocon
12.7.1 Biocon Company Details
12.7.2 Company Description and Business Overview
12.7.3 HER2 Antibodies Introduction
12.7.4 Biocon Revenue in HER2 Antibodies Business (2014-2019)
12.7.5 Biocon Recent Development
12.8 Novus Biologicals
12.8.1 Novus Biologicals Company Details
12.8.2 Company Description and Business Overview
12.8.3 HER2 Antibodies Introduction
12.8.4 Novus Biologicals Revenue in HER2 Antibodies Business (2014-2019)
12.8.5 Novus Biologicals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details